IMUNON is on track to initiate the 500-patient Phase 3 trial of IMNN-001 in the first quarter of 2025. How did the FDA respond to IMUNON's CMC strategy ... treatments that harness the body ...

Company aligned with FDA on CMC strategy and requirements in preparation ... IMUNON remains on track to initiate the 500-patient Phase 3 trial of IMNN-001 in the first quarter of 2025.

One in every 13 prescriptions in the US is a generic from Teva. Now, CEO Richard Francis is focusing on drug development, delivering better medications faster.

lse.ac.uk Background Patient complaints have been identified as a valuable resource for monitoring and improving patient safety. This article critically reviews the literature on patient complaints, ...

Local calls: To make a free local call, dial 9 and then the 10-digit phone number you’re calling. For example, 9-614-555-1234. The name and phone number for each patient’s nurse or patient care ...

Amazon has been elbowing its way into healthcare, selling medical devices online, running its own pharmacy and, most recently, operating a chain of clinics, called Amazon One Medical. But an ...

Provide ready and sustained health services support and force health protection in support of the Total Force to enable readiness and to conserve the fighting strength while caring for our People ...